Clinical Guides
Primary Aldosteronism
A clinically focused, India-adapted guide to primary aldosteronism screening, potassium-safe biochemical interpretation, medication interference, adrenal imaging and venous sampling, subtype-directed surgery, mineralocorticoid-receptor blockade and pregnancy planning.
MedNext Academy | 13 min read
Primary Aldosteronism
A clinically focused, India-adapted guide to primary aldosteronism screening, potassium-safe biochemical interpretation, medication interference, adrenal imaging and venous sampling, subtype-directed surgery, mineralocorticoid-receptor blockade and pregnancy planning.
Summary
Primary aldosteronism is autonomous or inappropriately high adrenal aldosterone production relative to renin. Sodium retention, volume expansion and potassium and hydrogen loss produce hypertension with or without hypokalaemia; normal potassium does not exclude disease. Compared with blood-pressure-matched primary hypertension, untreated aldosterone excess is associated with greater cardiovascular, renal and metabolic harm, making specific treatment important. The diagnostic pathway has distinct questions: who should be screened, whether aldosterone is renin-independent, whether confirmation adds value, and whether secretion is unilateral or bilateral. Screening measures morning seated plasma or serum aldosterone and renin, with potassium measured concurrently and sodium restriction avoided beforehand. Assay, posture, medicines, kidney function, age and hypokalaemia alter interpretation. Correct low potassium because it can suppress aldosterone and yield a false-negative result. A ratio alone is not a diagnosis; examine aldosterone, renin and pre-test probability. Patients pursuing curative surgery usually require adrenal CT and adrenal venous sampling, because small nonfunctioning nodules are common and CT cannot reliably identify the secreting side. Unilateral disease can be treated with laparoscopic adrenalectomy; bilateral disease, unknown lateralisation or unsuitable surgery is treated with a mineralocorticoid-receptor antagonist, with epithelial sodium-channel blockade in selected intolerance. Monitor pressure, potassium, kidney function and renin-guided response. Pregnancy requires specialist preconception planning because commonly used antagonists have fetal implications. This quarantined guide supports supervised learning, not self-directed drug withdrawal, salt loading, venous sampling or surgery.
How Common Is It?
Primary aldosteronism is more common than the older image of a rare hypokalaemic adrenal tumour suggests. Prevalence depends on whom and how one tests: it rises across unselected hypertension, more severe or resistant hypertension, adrenal incidentaloma and specialist referral cohorts. Many affected people are normokalaemic, so requiring spontaneous hypokalaemia misses clinically important disease. The 2025 Endocrine Society guideline therefore suggests screening people with hypertension rather than reserving testing for a narrow classic phenotype, although implementation depends on resources, laboratory quality and whether a positive result can lead to specific treatment. Published estimates from other health systems cannot be converted into an exact Indian national burden. India has a large hypertensive population but uneven access to renin and aldosterone assays, medication substitution, confirmatory testing and adrenal venous sampling; recorded prevalence will reflect these service constraints. Pre-test probability is especially meaningful in resistant hypertension, hypertension with spontaneous or diuretic-associated hypokalaemia, an adrenal mass, early-onset hypertension or stroke, sleep apnoea, unexplained worsening control, or atrial fibrillation without another cause. Familial forms are uncommon but matter in very young onset and affected families. Primary aldosteronism is not synonymous with Conn adenoma: bilateral adrenal hyperplasia is frequent and may produce milder biochemistry. The condition should be viewed as a spectrum of renin-independent aldosterone excess. Epidemiological uncertainty supports better detection and registries, not inflated claims that every case of hypertension is endocrine or that one laboratory cut-off fits every Indian assay.
Risk Factors
The clinical factors that raise pre-test probability are increasing hypertension severity, resistant hypertension despite an appropriate multi-drug regimen, control requiring several medicines, spontaneous or diuretic-induced hypokalaemia, an adrenal incidentaloma, young-onset hypertension, a family history of early hypertension or stroke, and a first-degree relative with established primary aldosteronism. Obstructive sleep apnoea, unexplained atrial fibrillation and progressive hypertension can also prompt screening. These are case-detection clues rather than proven causes. Most patients have sporadic bilateral hyperplasia or a unilateral aldosterone-producing adenoma. Familial hyperaldosteronism should be considered with onset before age 20, multiple affected relatives, early cerebrovascular events or a known germline variant; genetics review selects testing and counsels relatives. Cardiometabolic comorbidity, chronic kidney disease and older age do not protect against disease, but they complicate renin interpretation and decisions about salt loading, surgery and medication. A visible adrenal nodule increases attention but does not establish lateralisation: incidental nonfunctioning adenomas become more common with age. Conversely, a normal CT does not exclude unilateral microscopic secretion. Pregnancy may reveal or modify hypertension and potassium disturbance, but renin and aldosterone physiology changes substantially, so standard thresholds cannot be copied uncritically. There is no defensible claim that stress, dietary indiscretion or personality causes an aldosterone-producing adenoma. High sodium intake can amplify aldosterone-mediated injury, but imposing sodium restriction immediately before screening may raise renin and obscure interpretation. Assess liquorice, supplements and medicines because apparent mineralocorticoid states and assay distortion can mimic or mask the diagnosis.
Diagnosis
History
Document hypertension onset, serial readings, adherence, exact drug doses, diuretic exposure and home technique. Ask about weakness, cramps, polyuria, nocturia, thirst, palpitations and previous potassium results, while remembering that many patients are asymptomatic and normokalaemic. Record kidney and heart disease, sleep apnoea, adrenal imaging, family hypertension or young stroke, pregnancy intentions and liquorice or supplement use.
Examination
Confirm blood pressure with appropriate cuff and repeated or ambulatory measurements when available. Assess orthostasis, volume status, arrhythmia, heart failure, retinopathy, vascular disease and neurological deficit. Look for alternative endocrine syndromes, but phenotype alone cannot subtype aldosterone secretion. Severe hypertension or arrhythmia with profound hypokalaemia requires stabilization before elective testing.
Investigations
Screen in the morning with the patient seated, without deliberate sodium restriction, measuring aldosterone, renin and potassium together. Interpret absolute aldosterone plus suppressed renin and the laboratory-specific ratio; units and assay method matter. Correct hypokalaemia and repeat a negative test if suspicion remains. Medication strategy may use no-withdrawal or minimal withdrawal when safety limits substitution. Mineralocorticoid antagonists, amiloride, triamterene and other diuretics can raise renin; ACE inhibitors and ARBs also lower the ratio, whereas beta-blockers and central alpha-2 agonists suppress renin and may create false positives. Confirmatory suppression testing is most useful at intermediate probability when surgery is desired, and can be omitted in specified overt biochemical or empiric-treatment pathways. Adrenal CT assesses anatomy and malignancy risk. A surgical candidate generally needs adrenal venous sampling by an experienced centre to distinguish unilateral from bilateral secretion; CT alone is insufficient.
Differential Diagnosis
Essential hypertension remains the most common explanation for elevated blood pressure, but it can coexist with an adrenal incidentaloma or low potassium. Secondary hyperaldosteronism from renovascular disease, malignant hypertension, diuretic use, heart failure, cirrhosis or nephrotic states has activated rather than suppressed renin and should not be relabelled primary aldosteronism. Renal artery stenosis is particularly important when kidney function falls after renin-angiotensin blockade, abdominal bruit or asymmetric kidneys are present. Cushing syndrome, pheochromocytoma, thyroid disease, hyperparathyroidism and obstructive sleep apnoea enter the endocrine differential according to clinical features. Low-renin hypertension with hypokalaemia can arise from liquorice or glycyrrhizin exposure, apparent mineralocorticoid excess, Liddle syndrome, glucocorticoid-remediable familial disease, deoxycorticosterone excess or severe cortisol excess. These conditions often have low renin with low aldosterone, distinguishing them from autonomous aldosterone when testing is reliable. Gastrointestinal potassium loss, renal tubular disorders, magnesium deficiency and diuretics can explain hypokalaemia without aldosterone excess. False biochemical patterns are common: beta-blockers and clonidine suppress renin; ACE inhibitors, ARBs, diuretics, sodium restriction and mineralocorticoid antagonists may raise it; hypokalaemia can lower aldosterone; chronic kidney disease changes both hormones. A unilateral adrenal nodule may be nonfunctioning while aldosterone secretion is bilateral or contralateral. Adrenal carcinoma rarely secretes aldosterone but should be considered when imaging is large, heterogeneous or invasive. Diagnosis therefore integrates physiology, assay and anatomy rather than equating a high ratio or a CT nodule with Conn syndrome.
Management
Treatment targets aldosterone-mediated harm as well as the cuff blood pressure. A patient with convincingly unilateral secretion who desires and can undergo surgery is offered total unilateral adrenalectomy, usually laparoscopic, after endocrine, radiological, anaesthetic and surgical assessment. Adrenal venous sampling ordinarily establishes lateralisation because CT can miss a small adenoma or misassign an age-related incidental nodule. A narrow possible exception is a very young patient with marked biochemical disease, hypokalaemia and a clear unilateral adenoma, decided in an expert team. Before surgery, control pressure and correct potassium, usually with mineralocorticoid blockade and other antihypertensives; document renal function and exclude other functional adrenal disease as indicated. After adrenalectomy, stop or reduce potassium and antihypertensives under supervision, monitor for hyperkalaemia, hypotension and kidney-function change, and reassess biochemical and clinical outcome. Bilateral disease, unknown lateralisation, declined surgery or unacceptable operative risk is treated long term with a mineralocorticoid-receptor antagonist. Spironolactone is widely used; eplerenone may reduce antiandrogenic or progestogenic adverse effects but can be costlier and require different dosing. Amiloride is an alternative when antagonists are not tolerated or are contraindicated, though it does not block the receptor directly. Titrate using blood pressure, potassium, renal function and renin response, alongside dietary sodium reduction after diagnostic sampling. Evidence for exact renin targets and universal screening implementation has limitations; personalize intensity, measure outcomes and avoid promising surgical cure before postoperative assessment.
Prescribing Information
Mineralocorticoid-receptor antagonists can correct potassium quickly and lower blood pressure over weeks, so safe initiation requires a baseline potassium and estimated glomerular filtration rate, a plan for early repeat testing and review of ACE inhibitors, ARBs, NSAIDs, trimethoprim, potassium supplements and salt substitutes. Spironolactone may cause breast tenderness, gynaecomastia, menstrual disturbance, sexual adverse effects and hyperkalaemia. Eplerenone is more selective but often more expensive and can interact through CYP3A4; verify the current Indian product information and formulary. Amiloride blocks ENaC and can also cause hyperkalaemia. Do not combine these agents or continue potassium supplements automatically. The Endocrine Society algorithm prioritizes blood-pressure control, normokalaemia and reversal of renin suppression, with potassium, renal function, blood pressure and renin reviewed after initiation or titration. A rise in creatinine may reflect reversal of aldosterone-related hyperfiltration, but progressive acute kidney injury still requires evaluation. During diagnostic preparation, never withdraw antihypertensives merely to obtain a clean ratio if severe hypertension, heart failure or arrhythmia makes that unsafe. A specialist may substitute drugs with less effect on renin and aldosterone, use a minimal-withdrawal schedule, or interpret results on treatment. Hypokalaemia must be corrected because low potassium can falsely lower aldosterone. In pregnancy, spironolactone is generally avoided because of antiandrogenic fetal concern; eplerenone and amiloride have limited pregnancy evidence and require maternal-fetal medicine and endocrine decisions. No internet dose can replace individualized prescribing, laboratory timing and sick-day advice.
When to Refer
Refer to endocrinology or a hypertension service after a positive or repeatedly equivocal screen, severe or resistant hypertension with suppressed renin, unexplained spontaneous or diuretic-associated hypokalaemia, hypertension with an adrenal mass, very young onset, or a family pattern suggesting familial hyperaldosteronism. Include dates and values for aldosterone, renin, ratio, potassium, creatinine and bicarbonate; exact units and assay; posture and collection time; sodium intake; every medicine and withdrawal interval; blood-pressure record; adrenal images rather than report alone; comorbidities; and pregnancy intentions. Refer a patient who wishes to consider surgery to a centre with high-quality adrenal CT interpretation, experienced adrenal venous sampling and endocrine surgery. AVS is technically demanding and a failed or mislabelled sample can direct the wrong adrenalectomy; local procedural volume and interpretation matter. Genetics input is appropriate for established familial disease, onset before age 20 or a striking family history. Same-day emergency referral is required for severe hypertension with neurological deficit, chest pain, pulmonary oedema, aortic symptoms, acute kidney injury, encephalopathy or dangerous hypokalaemia with ECG change or arrhythmia. Pregnancy with severe hypertension or persistent hypokalaemia needs urgent obstetric-medicine and endocrine coordination rather than routine outpatient medication switching. In India, access constraints may justify starting monitored mineralocorticoid blockade in a patient who cannot pursue AVS or surgery, but empirical treatment must remain explicit and safety monitored. Referral letters should state whether the goal is diagnosis, lateralisation, surgery, genetic assessment or difficult medical control.
Red Flags
A hypertensive emergency is defined by acute target-organ injury, not a blood-pressure number alone. Focal neurological deficit, seizure, confusion, retinal emergency, chest pain, acute pulmonary oedema, aortic pain, oliguria or rapidly worsening creatinine requires immediate hospital assessment and controlled blood-pressure reduction according to the affected organ. Profound hypokalaemia can cause weakness, paralysis, rhabdomyolysis, ileus, ventricular arrhythmia and sudden death; obtain ECG, magnesium and repeat a non-haemolysed potassium, replace under monitoring and investigate ongoing renal loss. Do not delay stabilization to preserve diagnostic purity. After starting spironolactone, eplerenone or amiloride, new weakness, bradycardia, conduction change, oliguria or acute illness may signal hyperkalaemia or kidney injury and needs urgent testing. After unilateral adrenalectomy, hypotension, hyperkalaemia, falling renal function, bleeding, fever or severe abdominal pain requires surgical and endocrine review. Imaging red flags include a large, heterogeneous, irregular, rapidly growing or invasive adrenal mass; assess for malignancy and other hormone excess, and exclude pheochromocytoma before biopsy or operation. During pregnancy, severe hypertension, headache, visual symptoms, epigastric pain, fetal compromise or rapidly changing laboratory values must be assessed for obstetric emergencies even when primary aldosteronism is known. Conversely, suppressed renin and hypokalaemia should not lead clinicians to overlook vomiting, diuretics, renal disease or inherited tubular conditions. Safety comes first: stabilize pressure and potassium, then repeat controlled endocrine testing once the acute state permits reliable interpretation.
Indian Clinical Context
Reliable aldosterone-renin testing is not uniform across India. Reports may use plasma renin activity or direct renin concentration and aldosterone in different units, so copied ratio thresholds are dangerous. Each laboratory should state method, reference interval, collection conditions and validated decision limits. Coordinate morning seated sampling, avoid sodium restriction for several days, correct potassium and document drugs. When withdrawal is unsafe or travel makes repeated visits burdensome, the 2025 guideline’s no-withdrawal or minimal-withdrawal strategies can support interpretation, but they require explicit awareness of false-negative and false-positive directions. Access to saline infusion or other suppression tests varies, and sodium loading may be unsafe in uncontrolled hypertension, heart failure or kidney disease. Treatment can proceed empirically with monitored mineralocorticoid blockade when AVS and surgery are not desired or feasible. CT is more available than AVS, but removing an adrenal solely because a nodule is visible is a bad idea because discordant or bilateral secretion is common. Build referral pathways to centres that perform AVS regularly and can report selectivity and lateralisation indices under an explicit protocol. Generic spironolactone is affordable but adverse effects and potassium monitoring can limit adherence; eplerenone availability and cost vary. Counsel in the patient’s language, provide a written laboratory plan, and integrate primary-care blood-pressure follow-up. Pregnancy care needs joint endocrine and maternal-fetal expertise. International recommendations inform care but do not override Indian drug labels, institutional protocols, resource realities or patient preference, and the evidence supporting several testing and treatment recommendations is low certainty.
NMC Competency Mapping
The NMC CBME Curriculum 2024 anchors this topic across physiology, pharmacology, medicine, pathology and surgery. Physiology PY8.4 requires understanding adrenal hormone synthesis, secretion, actions, altered secretion and function tests; renal physiology links aldosterone to distal sodium retention, potassium secretion, acid-base balance and renin regulation. Pharmacology learning on diuretics, renin-angiotensin system drugs and potassium-sparing agents supports interpretation of assay interference, mineralocorticoid-receptor antagonism and hyperkalaemia risk. Medicine competencies on hypertension, electrolyte disorders and endocrine disease support case detection and emergency assessment. Pathology and surgery teaching provide the distinction between hyperplasia, adenoma and malignant adrenal lesions and principles of adrenal intervention. Obstetric competencies are relevant when hypertension or potassium disturbance occurs in pregnancy. A graduating learner should be able to explain low-renin aldosterone excess, state that normokalaemia does not exclude it, recognize resistant-hypertension clues, and interpret why correction of hypokalaemia and medication review precede screening conclusions. They should distinguish secondary hyperaldosteronism, describe why CT does not replace AVS for most surgical candidates, and compare unilateral adrenalectomy with long-term receptor blockade. Learners must recognize hypertensive emergency and dangerous potassium disturbance. Competency mapping does not authorize unsupervised withdrawal of antihypertensives, salt-loading tests, AVS interpretation, adrenalectomy or pregnancy prescribing. Faculty should use supervised cases and local laboratory examples and verify exact competency numbering against the current NMC curriculum rather than relying on an older handout.
Key Exam Pearls for NEET PG
Primary aldosteronism means aldosterone secretion is inappropriately autonomous with suppressed renin. The physiological pattern is hypertension, sodium retention, potassium loss and metabolic alkalosis, but hypokalaemia is not obligatory. Screen with morning seated aldosterone and renin while avoiding recent sodium restriction, and measure potassium concurrently. Correct a low potassium before judging a negative result because hypokalaemia can suppress aldosterone. Interpret aldosterone, renin and the ratio together using assay-specific units. Mineralocorticoid antagonists, amiloride, triamterene and other diuretics tend to raise renin and can cause false negatives; ACE inhibitors and ARBs may do likewise. Beta-blockers and central alpha-2 agonists suppress renin and can create a false-positive ratio. Never stop these drugs automatically when cardiovascular risk makes withdrawal unsafe. Confirmation is most useful for intermediate probability when the patient wants a surgical pathway; overt renin-independent biochemistry or an empirical medical pathway may not need it. CT characterizes adrenal anatomy and excludes concerning large lesions, but does not reliably lateralize aldosterone secretion. Most operative candidates therefore need adrenal venous sampling. Unilateral secretion is treated with unilateral adrenalectomy; bilateral or unlocalized disease is treated with spironolactone or another mineralocorticoid-directed agent. Monitor blood pressure, potassium, kidney function and renin. A postoperative fall in hyperfiltration can uncover chronic kidney disease. In pregnancy, do not reflexively prescribe spironolactone; obtain specialist advice. High-yield differentials with low renin and low aldosterone include Liddle syndrome and apparent mineralocorticoid excess.
Frequently Asked Questions
Can primary aldosteronism occur when the potassium concentration is normal?
Yes. Many affected patients are normokalaemic, particularly with milder or bilateral disease. Potassium is important for safety and interpretation but is not an adequate screening test. Suspicion should be based on the hypertension phenotype and aldosterone-renin testing performed under documented conditions.
Must all blood-pressure medicines be stopped before aldosterone-renin screening?
No. Withdrawal can be dangerous and is not always necessary. The current guideline describes no-withdrawal and minimal-withdrawal strategies. Clinicians document each medicine, understand its likely effect, correct hypokalaemia and repeat or modify testing only when safe and when the result would change management.
Why is adrenal venous sampling needed when CT already shows one adrenal nodule?
CT shows anatomy, not which gland is secreting aldosterone. A visible nodule may be nonfunctioning, secretion may be bilateral, and a small contralateral source may be invisible. AVS compares adrenal venous hormone secretion and usually prevents surgery on the wrong side in appropriate operative candidates.
Is surgery always better than mineralocorticoid-receptor antagonist treatment?
No. Surgery is mainly for convincingly unilateral disease in a patient who wants and can undergo adrenalectomy. Bilateral or unlocalized disease is usually treated medically. Choice also depends on comorbidity, AVS access, adverse effects, monitoring, cost and patient preference; neither pathway guarantees complete withdrawal of all antihypertensives.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic